logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Postal Savings Bank: Registered capital changed to RMB 1200.95 billion.

date
02/04/2026
Postal Savings Bank Announcement: Recently, our bank received the "Reply of the China Banking and Insurance Regulatory Commission on the Change of Registered Capital of Postal Savings Bank," which approved the change of our bank's registered capital to 120.95 billion RMB. Our bank will revise the relevant articles of the company's articles of association according to the reply.
Latest
5 m ago
Laisi Information won the bid for the provincial-level low-altitude flight comprehensive management service platform project in Liaoning Province.
6 m ago
State Grid's fixed asset investment in the first quarter was nearly 130 billion yuan.
7 m ago
The second quarter provincial major project construction work conference was held in Xuchang in 2026. Liu Ning attended and delivered a speech, while Wang Kai presided over the meeting.
9 m ago
A report jointly released by the United Nations, the African Union, and the African Development Bank pointed out that prolonging the duration of the Gulf War will cause a 0.2 percentage point decrease in Africa's GDP growth rate in 2026.
9 m ago
Chi Fei Biotech announced that the company signed a revised and restated supply, distribution, and co-promotion agreement with MSD on April 2, 2026. The original agreement will terminate upon the effectiveness of the new agreement. The new agreement aims to deepen the strategic cooperation between the two parties, enhance market synergy, address operational pressures, and includes products such as the nine-valent HPV vaccine. The cooperation period extends until the end of 2028 and may be extended for two years. The company will adjust procurement and supply quantities dynamically based on market demand, and performance under the agreement will be disclosed regularly. The new agreement no longer specifies a base purchase amount for the agreement products. Chi Fei Biotech and MSD will negotiate and confirm expected procurement and supply plans based on market expectations and actual vaccination situations. The company will then procure the agreement products on a rolling basis. Specific procurement details will be based on orders confirmed in writing by both parties.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.